TrialCancer chemotherapy and pharmacology2013

Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double‑blind, placebo‑controlled trial of goshajinkigan to prevent oxaliplatin‑induced neuropathy.

Toru Kono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.